- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Portopulmonary Hypertension in Hong Kong
Total 158 results
-
Boehringer IngelheimCompletedCombination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaHypertension | DyslipidemiasTaiwan, Netherlands, Czech Republic, France, Germany, Hong Kong, Korea, Republic of, Russian Federation, Slovakia, South Africa, Sweden, Ukraine
-
ActelionCompletedPulmonary Arterial HypertensionUnited States, United Kingdom, Belarus, Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, China, Colombia, Croatia, France, Germany, Hong Kong, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland and more
-
Daiichi Sankyo, Inc.Completed
-
TakedaCompletedHypertensionUnited States, Chile, Mexico
-
ActelionCompletedPulmonary Arterial HypertensionUnited States, United Kingdom, Taiwan, Finland, Canada, Belarus, Belgium, Argentina, Australia, China, Colombia, Croatia, Germany, Hong Kong, India, Israel, Italy, Malaysia, Netherlands, Poland, Russian Federation, South Africa, Tha... and more
-
The George InstituteNational Health and Medical Research Council, AustraliaCompletedStroke | Hypertension | Intracerebral HemorrhageUnited States, France, Australia, Hong Kong, Finland, Germany, Spain, Argentina, Austria, Belgium, Brazil, Chile, China, India, Italy, Pakistan, Portugal, Switzerland, United Kingdom
-
Forest LaboratoriesCompletedHypertensionUnited States, Puerto Rico
-
Advanced-JJapan Heart FoundationUnknownHypertension | Diabetes Mellitus, Type 2Japan
-
PfizerCompletedHypertension | Blood Pressure, HighUnited States
-
TakedaCompletedHypertensionUnited States, Puerto Rico
-
Idorsia Pharmaceuticals Ltd.CompletedEssential HypertensionUnited States, Canada, Israel, Puerto Rico
-
TakedaCompletedEssential HypertensionUnited States, Chile, Mexico
-
Ligand PharmaceuticalsCompletedHypertensionUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaBrazil, Turkey, Taiwan, Argentina, India, Philippines, Singapore, Thailand, Australia, Chile, South Africa, Jordan, Korea, Republic of, Lebanon, United Arab Emirates, Malaysia, Peru, Israel, Indonesia, Guatemala, Hong Kong, Kuwait, ... and more
-
TakedaCompletedHypertensionUnited States, Mexico, Argentina
-
Forest LaboratoriesCompletedStage 2 Diastolic HypertensionUnited States, Puerto Rico
-
Daiichi Sankyo, Inc.Completed
-
Forest LaboratoriesCompleted
-
BioMarin PharmaceuticalCompletedHypertensionUnited States
-
NovartisIntegrium; Great Lakes Drug Development, Inc.CompletedHypertensionUnited States, Iceland
-
Boehringer IngelheimBayer; GlaxoSmithKlineCompletedHypertensionUnited States, Canada
-
AbbVieEnrolling by invitationOcular Hypertension | Open-Angle GlaucomaUnited States, Argentina, Belgium, Brazil, Canada, Colombia, Czechia, Denmark, Egypt, France, Germany, Hong Kong, Italy, Korea, Republic of, New Zealand, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Thailan... and more
-
TakedaCompletedHypertensionUnited States, Mexico, Chile, Peru
-
Forest LaboratoriesCompletedStage 2 Hypertension | Stage 1 HypertensionUnited States
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedHypertensionSpain, Italy, Netherlands, United States, Denmark, Taiwan, Argentina, Germany, Russian Federation, Slovakia, Canada, Hungary, Latvia, Lithuania, Poland, Finland, France, Sweden
-
NicOxCompletedHypertension | OsteoarthritisUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
AstraZenecaRecruitingResistant Hypertension | Uncontrolled HypertensionCanada, United States, South Africa, Korea, Republic of, Australia, Poland, Belgium, Japan, Spain, Vietnam, Argentina, Bulgaria, Turkey, Germany, Malaysia, Taiwan, Thailand, Italy, France, Israel, India, Netherlands, Sweden, United Kingdom and more
-
Novartis PharmaceuticalsCompletedHypertensionUnited States, Spain, Philippines, Guatemala, Russian Federation, Argentina, Puerto Rico
-
TakedaCompletedHypertensionUnited States, Argentina, Peru, Mexico
-
United TherapeuticsTerminatedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Boehringer IngelheimCompleted
-
United TherapeuticsCompletedPulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and EmphysemaUnited States, Puerto Rico
-
Boehringer IngelheimCompletedHypertensionUnited States, Canada
-
Boehringer IngelheimCompleted
-
VA Office of Research and DevelopmentCompleted
-
Boehringer IngelheimCompletedHypertensionUnited States, Bulgaria, Czech Republic, France, Hungary, Korea, Republic of, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
AllerganCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Korea, Republic of, Mexico, Netherlands, Slovakia, South Africa, Spain, Sweden
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Brazil, Mexico, South Africa
-
Forest LaboratoriesCompletedHypertensionUnited States
-
Bristol-Myers SquibbSanofiCompletedHypertensionUnited States, Canada, Germany, Russian Federation, France
-
Theravance BiopharmaCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Canada, Chile, Mexico, Peru
-
Daiichi Sankyo, Inc.Completed
-
Alnylam PharmaceuticalsActive, not recruitingHypertensionUnited States, Canada, Latvia, Poland, United Kingdom, Germany, Lithuania, Estonia, Puerto Rico
-
AbbVieRecruiting
-
Daiichi Sankyo, Inc.CompletedHypertensionUnited States, Puerto Rico